Abstract
Atrial natriuretic peptide (ANP) which alters sodium balance, blood volume and vascular tone represents an important candidate for investigating the genetic basis of essential hypertension (EH). Accordingly, we have studied Bgl1 and Xho1 restriction fragment length polymorphisms (RFLPs) of the ANP gene in 147 hypertensive, 141 normotensive and 67 population-based control subjects from a homogenous population of West African origin from St Vincent and the Grenadines. We found no association of either Bgl1 and Xho1 RFLPs with EH. This study suggests that the ANP locus may not exert a major gene effect on EH amongst the black people of St Vincent and the Grenadines.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Daniel, H., Munroe, P., Kamdar, S. et al. The atrial natriuretic peptide gene and essential hypertension in African-Caribbeans from St Vincent and the Grenadines. J Hum Hypertens 11, 113–117 (1997). https://doi.org/10.1038/sj.jhh.1000389
Received:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1000389
Keywords
This article is cited by
-
A review of the role of atrial natriuretic peptide gene polymorphisms in hypertension and its sequelae
Current Hypertension Reports (2009)